Best Biotech Stocks To Buy Under $10 May 2026

Currently receiving an from analysts at Wolfe Research , with a price target of $7.

The company recently expanded its pipeline by acquiring DMX-200 for kidney disease.

: Highlighted for strengthening its global reach through strategic deals, such as the one with Kyowa Kirin. best biotech stocks to buy under $10

While reporting a net loss in mid-2025, it reaffirmed revenue growth guidance of 15–22%. : Trading around $8.05 as of April 2026.

Consistently featured in lists of best biotechs under $10 and is noted for its Cancer BioShield platform targeting lymphopenia. Currently receiving an from analysts at Wolfe Research

The primary catalyst is upcoming clinical data for ulcerative colitis, expected in the second half of 2027.

Searching for biotech stocks under $10 reveals several companies with strong analyst backing and significant upcoming catalysts. As of late 2025 and early 2026, the following stocks are frequently highlighted by financial experts for their growth potential: Top Rated Biotech Stocks Under $10 : While reporting a net loss in mid-2025, it

: Noted for its inhaled therapy for pulmonary arterial hypertension and its recent pursuit of FDA pediatric approval.